Please login to the form below
monoclonal antibodies
This page shows the latest monoclonal antibodies news and features for those working in and with pharma, biotech and healthcare.
Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
access to our monoclonal antibodies.
Latest news
-
AstraZeneca and UK-based biotech company RQ BIO sign licencing agreement
RQ BIO has developed a portfolio of early-stage monoclonal antibodies targeting SARS-CoV-2. ... AstraZeneca has signed a new licencing agreement with UK-based biotechnology company, RQ BIO, for its portfolio of early-stage monoclonal antibodies targeting
-
Sanofi begins construction on the first of two Evolutive Vaccine Facilities in Singapore
The EVFs have been designed to accommodate the ‘agile and flexible’ production of multiple vaccine and biologics platforms, including mRNA, enzymes and monoclonal antibodies.
-
Celltrion submits application for inhaled COVID-19 antibody treatment
The COVID-19 antibody cocktail is made up of regdanvimab and CT-P63, with the two monoclonal antibodies combined to target new strains of coronavirus, including the highly transmissible Omicron variant.
-
FDA restricts use of certain antibody treatments for COVID-19
These monoclonal antibodies are now limited to cases “only when the patient is likely to have been infected with or exposed to a variant that is susceptible to these treatments”. ... The statement did not entirely rule out a future use of the
-
Gilead’s Veklury receives FDA approval for non-hospitalised high-risk patients to treat COVID-19
The approval follows a rapid increase in COVID-19 cases coupled with the reduced sensitivity to various anti-SARS-CoV-2 monoclonal antibodies due to the recent and highly-transmissible Omicron
More from news
Approximately 2 fully matching, plus 111 partially matching documents found.
Latest Intelligence
-
How early-stage clinical research is facilitating the new wave of personalised medicines
More recently, we have increasingly trialled monoclonal antibodies instructing the immune system to destroy the target, which is often a faulty protein.
-
Surviving cancer: a new era for patients
Monoclonal antibodies have given rise to many promising therapies with equally promising clinical results. ... One such example is through the development of antibody-drug conjugates (ADC) – monoclonal antibodies attached to biologically active
-
Cortellis Drugs to Watch in 2020 report
Triptans are considered first-line therapy for the acute treatment of migraine and are widely available generically, although the market is undergoing transformation by prophylactic options such as CGRP monoclonal antibodies. ... It will face competition
-
Combined immunotherapies – potential and pitfalls
The recent failed phase 3 trial of a combination of MSD’s monoclonal antibody Keytruda (pembrolizumab) and InCyte Corporation’s epacadostat in metastatic melanoma is a case in point he says. ... This has shaped industry development strategies, said
-
The good, the bad and the ugly
Three CGRP monoclonal antibodies will launch in the US for migraine in 2018 - with a fourth anticipated in 2019.
More from intelligence
Approximately 0 fully matching, plus 19 partially matching documents found.
Latest appointments
-
F-star appoints GSK's Neil Brewis
Brewis joins from GlaxoSmithKline where he served as vice president and head head of biopharmaceutical research, leading a global team of 300 scientists who advanced numerous monoclonal antibodies, antibody fragments, and
-
V Bryan Lawlis joins board of KaloBios
patient-targeted, monoclonal antibodies towards commercialisation,” said David Pritchard, president and CEO of KaloBios. ... This includes three antibodies in development: one for inflammatory disease, one for lung infection and one for cancer.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Products as portfolios: positioning immuno-oncology products
Within blood cancers, PD-(L) 1s and also monoclonal antibodies, in particular CD38s, are redefining the approach to treatment.
-
ASCO 2015: What you missed in Chicago
Three monoclonal antibodies were presented on the last day of ASCO - two in multiple myeloma and one in amyloidosis. ... For years, leukaemia and lymphoma patients have benefited from power of monoclonal antibody treatment while plasma cell malignancies
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Live Webinar: Navigating the Nuances of Europe's MedTech Industry
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Novartis endorses Kigali Declaration by investing $250m for tropical diseases
- Pfizer, Mylan move ahead with generics merger and spin-out
PMHub
Madmicrobe Studios - Medical Animation
MadMicrobe is an award-winning team of certified medical illustrators creating animations that engage your audience with immersive experiences that bring...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
